Stay updated on FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Location in Italy updated from Padua to Padova (35128); the Padova site is now listed and the Padua listing removed.
    Difference
    0.0%
    Check dated 2026-04-04T19:00:47.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No changes to study data or page layout.
    Difference
    0.0%
    Check dated 2026-03-21T08:46:55.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; this seems to be a small internal site update with no visible changes to study content.
    Difference
    0.0%
    Check dated 2026-03-06T18:33:07.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Gastric cancer added as a related topic/keyword and Genetic and Rare Diseases Information Center resources linked; the page revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:41:49.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T15:39:58.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page adds a 'Show glossary' option and updates QC metadata to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing the older entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.1%
    Check dated 2026-01-29T09:22:30.000Z thumbnail image

Stay in the know with updates to FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.